An experimental version of CAR-T therapy doubled the survival time for children a deadly and aggressive form of brain cancer ...

A rare blood cancer, PV is marked by the overproduction of red blood cells, which significantly increases the risk of serious blood clots, especially in critical organs like the lungs, heart and ...

Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis Pharmaceuticals for the treatment of polycythemia vera (PV). The licence ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense ...

AB negative – he was considered a ‘universal donor of platelets’ which meant that anyone could receive his platelets without ...

The parents of brave Esha Nadeswaran are urging people to keep an eye out for symptoms of acute myeloid leukaemia ...

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

Huxley Bond was diagnosed with T-cell acute lymphoblastic leukaemia, a rare and aggressive blood cancer that affects the bone ...